Melanotan II – 10 mg
€ 34.99
In stock
Melanotan II is a synthetic melanocortin peptide studied for pigmentation, melanogenesis, UV response, and melanocortin receptor research. Research peptide for laboratory use only.
Product Description
Melanotan II (MT-II) is a synthetic cyclic heptapeptide, first developed at the University of Arizona as a stabilised analogue of alpha-melanocyte-stimulating hormone (alpha-MSH). Three structural modifications distinguish it from the native hormone: norleucine substitution, D-phenylalanine substitution, and lactam cyclisation between residues 2 and 7, which together confer resistance to enzymatic degradation and significantly increase receptor binding potency relative to native alpha-MSH.
What defines Melanotan II’s research profile is its non-selectivity. Unlike native alpha-MSH, which shows preferential activity at MC1R, MT-II activates all four melanocortin receptor subtypes it engages (MC1R, MC3R, MC4R, and MC5R) with broadly comparable, nano- to sub-nanomolar potency. This non-selective activation is what makes MT-II a valuable pharmacological probe for melanocortin system research, since it allows researchers to study effects across the full receptor family in a single compound, while also explaining why its observed effects in early studies extended well beyond pigmentation.
Pepta Supply provides Melanotan II as a lyophilized powder in 10 mg vials, independently HPLC-tested and batch-verified before dispatch.
Product Specifications
| Compound Name | Melanotan II (MT-II) |
| Compound Class | Synthetic cyclic heptapeptide, non-selective melanocortin agonist |
| Sequence | Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2 |
| Form | Lyophilized powder |
| Net Content | 10 mg per vial |
| Purity | 99% or above (HPLC-verified) |
| Molecular Weight | 1,024.2 g/mol |
| Molecular Formula | C50H69N15O9 |
| CAS Number | 121062-08-6 |
| Receptor Targets | MC1R, MC3R, MC4R, MC5R (non-selective) |
| Verification | Third-party HPLC, Certificate of Analysis via QR batch system |
| Storage | 2 to 8 degrees Celsius, protected from light and moisture |
| Intended Use | Research use only. Not for human or veterinary use. |
Research Background
Melanotan II’s broad receptor activation profile has made it a foundational tool compound in melanocortin system research since its development, used both in vitro and in vivo to probe the physiological roles of individual receptor subtypes within the wider melanocortin family.
MC1R: Pigmentation and Melanogenesis
MC1R is located on melanocytes and mediates eumelanin synthesis, the pigmentation pathway that gives Melanotan II its name. Activation of MC1R by MT-II stimulates melanogenesis, an effect that has been confirmed across decades of in vitro and in vivo research and remains the most consistently replicated finding in the MT-II literature. Case reports in the published literature have also documented darkening of pre-existing melanocytic nevi following exposure to melanocortin agonists, a finding attributed to MC1R-driven eumelanin synthesis in existing melanocytes, and an area noted as warranting continued research attention.
MC4R: Sexual Function and Energy Homeostasis
MC4R is the melanocortin receptor most critically implicated in energy homeostasis and sexual function research. MC4R-expressing neurons in the hypothalamic paraventricular nucleus project to the spinal cord, where they modulate erectile and sexual arousal responses. This pro-erectile effect was not part of MT-II’s original development as a tanning agent; it emerged as an unexpected finding in the first human pilot trials in the 1990s and subsequently redirected a significant portion of melanocortin research toward sexual function, eventually leading to the development of PT-141 (bremelanotide) as a more MC3R/MC4R-focused derivative. Separately, MC4R activation has been studied for its role in energy expenditure regulation, with research showing that MT-II administration increases oxygen consumption in lean and obese rodent models, an effect that is abolished in MC4R knockout mice, confirming the receptor’s central role in this pathway.
MC3R and MC5R: Appetite and Autonomic Effects
MC3R and MC5R activation by MT-II has been studied in the context of appetite suppression, altered cardiovascular tone, and changes in exocrine secretion. Intracerebroventricular administration of MT-II has been shown to suppress food intake in mouse models, and research using MC3R knockout mice has demonstrated that central MT-II administration reduces voluntary ethanol consumption through MC4R-dependent signalling, with the MC3R appearing to play a more specific role in binge-like drinking behaviour rather than moderate consumption. These findings have positioned MT-II as a research tool for studying the melanocortin system’s broader role in appetite, reward, and energy balance beyond its pigmentation effects.
Comparison to Selective Melanocortin Agonists
MT-II’s non-selectivity is both its primary research utility and its key limitation as a precision tool. Researchers studying receptor-specific effects often turn to more selective derivatives. Afamelanotide, an MC1R-selective analogue, completed a full regulated clinical development program and received FDA approval in 2019 as Scenesse for erythropoietic protoporphyria, producing pigmentation without MT-II’s MC4R-mediated effects. PT-141 (bremelanotide), also available in the Pepta Supply catalogue, was derived specifically to reduce MC1R activity while preserving MC3R/MC4R signalling, providing a more targeted tool for researchers studying sexual function pathways without the confounding variable of pigmentation change. SHU9119, a related research compound created by substituting D-Phe for 3-(2-naphthyl)-D-alanine in the MT-II structure, retains agonist activity at MC1R and MC5R but functions as an antagonist at MC3R and MC4R, making it a useful comparator tool for isolating receptor-specific effects.
Note: All findings above are from preclinical and early-stage human research. Melanotan II has not received regulatory approval for any therapeutic indication. Published controlled studies in humans remain limited in number, subject count, and duration, and no long-term safety data from prospective human trials are available.
Batch Verification and Quality
Each vial of Melanotan II from Pepta Supply carries a unique batch reference number. Independent third-party HPLC testing is carried out on every batch before it ships, confirming compound identity and purity at or above 99%. The resulting Certificate of Analysis is accessible via the QR code on the vial or through peptasupply.com/v/.
Storage and Handling
- Store lyophilized powder at 2 to 8 degrees Celsius, protected from light and moisture.
- Reconstitute with bacteriostatic water following standard laboratory protocols.
- Do not freeze the reconstituted solution.
- Use standard aseptic technique throughout handling and preparation.
- Consult relevant laboratory protocols for synthetic cyclic peptide handling.
| Research Use Only. Melanotan II is supplied exclusively for scientific and laboratory research. Not intended for human consumption, therapeutic, diagnostic, clinical, or veterinary use. Pepta Supply B.V. accepts no liability for misuse or non-compliant use. Buyers are fully responsible for compliance with applicable regulations in their country. |
Only logged in customers who have purchased this product may leave a review.
About the Compound
What is Melanotan II?
Melanotan II is a synthetic cyclic heptapeptide developed as a stabilised analogue of alpha-MSH. It carries norleucine substitution, D-phenylalanine substitution, and lactam cyclisation, modifications that increase resistance to enzymatic degradation and significantly boost receptor binding potency compared to native alpha-MSH. It acts as a non-selective agonist across MC1R, MC3R, MC4R, and MC5R.
What does non-selective mean in the context of MT-II's mechanism?
Native alpha-MSH shows preferential activity at MC1R, the receptor mediating skin pigmentation. Melanotan II activates all four melanocortin receptor subtypes it engages with broadly comparable, nano- to sub-nanomolar potency. This non-selectivity is what gives MT-II its broad research utility as a pharmacological probe of the melanocortin system, but it also means its effects are not confined to pigmentation, which is a key distinction from more receptor-selective compounds.
How was the pro-erectile effect of MT-II discovered?
The pro-erectile effect was not part of MT-II's original development as a tanning agent. It emerged as an unanticipated finding during the first human pilot trials in the 1990s, where researchers observed consistent activation of sexual arousal pathways via MC4R. This unexpected discovery redirected significant melanocortin research attention toward sexual function and directly led to the development of PT-141, a more receptor-focused derivative.
What is the relationship between Melanotan II and PT-141?
PT-141 (bremelanotide) was derived from MT-II's active metabolite with a lactam bridge modification that reduces MC1R activity while preserving MC3R and MC4R signalling. This gives researchers a more targeted tool for studying sexual arousal pathways without the confounding variable of pigmentation change associated with MC1R activation. Both compounds are available in the Pepta Supply catalogue, allowing comparative research between the non-selective and receptor-focused profiles.
What research has been done on MT-II and appetite regulation?
Intracerebroventricular administration of MT-II has been shown to suppress food intake in mouse models, an effect mediated primarily through MC4R and MC3R activation in hypothalamic circuits. Research has also documented that MT-II increases oxygen consumption (energy expenditure) in lean and obese rodent models, an effect abolished in MC4R knockout mice, confirming this receptor's central role in energy homeostasis regulation.
What is SHU9119 and how does it relate to MT-II?
SHU9119 is a related research compound created by substituting D-Phe for 3-(2-naphthyl)-D-alanine in the MT-II structure. Unlike MT-II, which is an agonist across the receptor family, SHU9119 retains agonist activity at MC1R and MC5R but functions as an antagonist at MC3R and MC4R. Researchers sometimes use MT-II and SHU9119 together as complementary tools to isolate which observed effects are MC3R/MC4R-dependent versus MC1R/MC5R-mediated.
Quality and Ordering
What purity does Pepta Supply's Melanotan II meet?
Pepta Supply's Melanotan II is tested to a purity of 99% or above, confirmed by independent third-party HPLC analysis on each batch. The Certificate of Analysis is batch-specific and accessible via the QR code on the vial or at peptasupply.com/v/.
What size does Melanotan II come in?
Melanotan II is available as a 10 mg lyophilized vial from Pepta Supply, listed under the Beauty and Aesthetics category, reflecting its primary research association with pigmentation and melanogenesis biology.
What EU delivery timeframe applies?
Orders placed before 3:00 PM on working days are dispatched the same day. Most EU destinations receive delivery within 1 to 3 business days. Free shipping applies to orders over 150 euros.
Is Melanotan II approved for human use?
No. Melanotan II has not received regulatory approval for any therapeutic indication. Published controlled human studies remain limited in scope and duration. Pepta Supply supplies it exclusively for qualified scientific and laboratory research in controlled environments.
| Content prepared for research-use-only positioning on peptasupply.com. No statements constitute medical claims or endorsement for human use. Prepared by SERPISTAN for Pepta Supply B.V. |








Reviews
There are no reviews yet.